PDUS+ 58/402 (14%) | ASAS+ (40, 69%) | ASAS− (18, 31%) | |||||
---|---|---|---|---|---|---|---|
14% (40/288) of all ASAS+ patients | 16% (18/109) of all ASAS− patients | ||||||
Imaging+ (29, 50%) | Clinical+ Imaging− (10, 17%) | ||||||
15% (29/189) of all Imaging+ | 10% (10/96) of all Clinical+ Imaging− (m=1) | ||||||
Rx+ MRI+ | Rx+ MRI− | Rx− MRI+ | CRP+ | CRP− | CRP+ | CRP− | |
13 | 8 | 8 | 1 | 9 | 3 | 14 | |
22% | 14% | 14% | 2% | 15% | 5% | 24% (m=1) | |
15%* | 22%* | 13%* | 8%* | 11%* | 16%* | 15%* |
↵* PDUS+ in each corresponding arm of all 402 patients.